NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization

NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, announced today that Nexsphere-F™, the company's novel fast resorbable microsphere for ...
European Medical Journal

Diabetes Drug Metformin Shows Potential in Osteoarthritis Care

Evidence from a clinical trial and long-term cohort studies suggests metformin, widely used in diabetes, may reduce knee ...